Yahoo Web Search

Search results

  1. Oct 24, 2018 · Statement objectives are to: 1) Summarize the current clinical evidence regarding ADHD, 2) Establish a standard for ADHD care, and. 3) Assist Canadian clinicians in making well-informed, evidence-based decisions to enhance care of children and youth with this condition. Specific topics reviewed in Part 1, which focuses on diagnosis, include ...

  2. Feb 17, 2023 · A robust body of evidence suggests that children with ADHD are at increased risk for other co-occurring conditions, including depression, anxiety, and substance use disorders (Asherson et al., 2016; Costa Dias et al., 2013).

  3. People also ask

  4. Mar 25, 2024 · Modafinil (US Food and Drug Administration [FDA]-approved to treat narcolepsy and sleep apnea but not ADHD) in each individual study significantly improved ADHD symptoms, but aggregated estimates were nonsignificant (SMD, −0.76; CI, −1.75 to 0.23; studies = 4; n = 667) (Fig 2, Supplemental Table 1) because of high heterogeneity (I 2 = 91%).

  5. Feb 27, 2014 · ADHD is the most prevalent neurodevelopmental disorder among children. In the United States, approximately 5.4 million children between 6 and 17 years of age (9.5% of all U.S. children) have ...

  6. Oct 24, 2018 · The DSM does not provide for developmental level differences, which may lead to overdiagnosis of ADHD in young preschool-aged children. 2. Symptoms are associated with impairment in academic achievement, peer and family relations and adaptive skills.

  1. People also search for